Security record · archived quarter
AMED
Amedisys, Inc. · Healthcare · Medical - Care Facilities
13Tracked holders
0Δ holders
3.10MShares held
$299.50MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +20.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2025 | 16 | 0 | 10.65M | $1.05B | — | — |
| Q1 2025 | 13 | -1 | 4.60M | $426.27M | — | −1 |
| Q4 2024 | 14 | 0 | 4.70M | $426.69M | — | — |
| Q3 2024 | 13 | 0 | 3.10M | $299.50M | +1 | −1 |
| Q2 2024 | 13 | — | 2.58M | $236.78M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 604.30K | +397.0% | $58.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 604.30K | +397.0% | $58.32M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 567.11K | +1.3% | $54.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 567.11K | +1.3% | $54.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 544.78K | -36.6% | $52.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 389.39K | 0.0% | $37.58M | 0.0% | Held | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 341.95K | +27.5% | $33.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 341.95K | +27.5% | $33.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 315.90K | +640.4% | $30.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Gotham Asset Management ✦ | 139.20K | +11.3% | $13.43M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 120.10K | -6.3% | $11.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 30.18K | -6.2% | $2.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 16.67K | +1.6% | $1.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 13.57K | New | $1.31M | 0.0% | New | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 12.82K | -52.5% | $1.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 7.17K | +7.8% | $691,977 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 7.17K | +7.8% | $691,977 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $1.31M | 0.0% |
Exited
| D. E. Shaw & Co. | $282,560 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $101 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API